Risk Management
| << Back |
Digest Vol 29 No 1 2019
Ophthalmologists examine many patients who are taking systemic medications that can cause ocular toxicity and a temporary decrease in visual acuity, or at worst, irreversible blindness.
Ophthalmologists may be the first clinicians to note adverse effects, or be asked to monitor for them. This issue of the Digest will review closed claims involving hydroxychloroquine, ethambutol, gentamicin, and amiodarone, and suggest risk reduction strategies for ophthalmic practices to implement.
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website
